The company announced positive Phase 1 results for a subcutaneous formulation of Briumvi, evaluating it against the currently ...
After previous disappointments with BTK inhibitors, a novel drug in this class is the first to show superiority to an active ...
The National MS Society has released a new report detailing the lived experiences of people with MS and highlighting unmet ...
ScienceAlert on MSN
World MS Day: Immune Cell Discovery Might Explain Multiple Sclerosis at Its Worst
A cross-section of the spinal cord showing neurons and glial cells. (Juan Carlos Juarez Jaramillo/iStock/Getty Images Plus) A ...
As recently as the ‘90s, when patients arrived with all the typical symptoms — memory loss, double vision, fatigue — neurologists often avoided confirming what they most suspected: that the patient ...
The Wistar Institute's Paul M. Lieberman, Ph.D., and lab team led by senior staff scientist and first author Samantha Soldan, Ph.D., have demonstrated how B cells infected with the Epstein-Barr virus ...
If you’ve been recently diagnosed with SPMS, you may wonder how the transition between RRMS and SPMS will affect your MS treatment options and lifestyle. Most people with MS are initially diagnosed ...
Multiple sclerosis (MS) could be "on the brink of a new class of treatment" after early trial results suggest two drugs may repair damage caused by the condition. A study led by the University of ...
Should multiple sclerosis (MS) patients stop disease-modifying treatment (DMT) as they get older? The answer depends on several factors, noted John Corboy, MD, of the Rocky Mountain MS Center at the ...
A generation ago, most people with multiple sclerosis could expect to rely on walkers and wheelchairs or be limited to their bed within 15 years of diagnosis. Today, UC San Francisco’s discoveries are ...
Onlymyhealth on MSN
Multiple sclerosis in men: Symptoms, causes, risk factors and treatment
Multiple sclerosis is an autoimmune condition that affects the nervous system, leading to nerve damage and chronic inflammation. While the exact cause of this disorder is unknown, experts believe ...
PARIS — The first real guidelines on the use of disease-modifying therapies in multiple sclerosis (MS) have been released by a European joint venture between the European Committee for Research and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results